Effect of Expanded Dulaglutide Weekly Doses on CVD Risk Factors in Participants With Type 2 Diabetes at Increased CVD Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study
Diabetes Obes Metab 2022 Sep 01;24(9)1770-1778, DA Cox, H Wang, C Nicolay, MA BethelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.